AXIS Clinicals announces Dr. Yati Chugh as CEO
Hyderabad, Jan. 15,
2013: AXIS
Clinicals Group, a leading global Clinical
Research Organization (CRO) announces the appointment of Dr. Yati Chugh as the Chief Executive Officer of AXIS Clinicals Limited.
Dr. Chugh assumes the responsibility for overall
activities of AXIS Clinicals Group companies with presence in India, Thailand
and Mexico. Under his able leadership and guidance, AXIS Clinicals team will ensure
that services are offered to partners with dedication, commitment, quality and
performance.
Dr. Chugh brings over two decades of experience in conducting pre-clinical,
Bioequivalence / Bioavailability (BA/BE) studies and clinical research. He has
extensive experience in areas of CNS, CVS, drug metabolism / pharmacokinetics
and clinical pharmacology.
“As AXIS Clinicals is one of the leading CRO’s of the country, that provides clinical studies on both male and female healthy
patient population in virtually all therapeutic areas, I am looking forward to our
continued leadership in delivering the AXIS Advantage of timely deliveries, accuracy
and quality in accordance to global standards to our clients & partners,” Dr. Yati Chugh, CEO said. “Our
fundamental focus is to provide our customers a complete clinical research
portfolio under one roof that will help them achieve the competitive advantage
needed in staying ahead,” he added.
Dr. Chugh holds a doctorate degree from PGIMER, Chandigarh and has
published about 45 scientific papers in reputed national and international
peer-reviewed journals. He has completed his Master’s and Ph.D in pharmacology from
PGIMER, Chandigarh and graduated in B.Pharm from Department of Pharmaceutical
Sciences, Punjab University, Chandigarh. He has about 25 patents to his credit
and is a member of all the major international bodies of pharmacology and is a
reviewer in major Journals of Pharmacology.
Prior to joining AXIS Clinicals, Dr.
Chugh was heading Lotus Labs as Managing Director. He has been associated with
several reputed biopharmaceutical companies like Wockhardt, Intas
Pharmaceuticals, Torrent Pharmaceuticals Limited for over two decades.
About
AXIS Clinicals
AXIS Clinicals Limited, one of India’s leading CRO is committed to serving the
biopharmaceutical industry by leveraging two
powerful trends impacting the world of Clinical Research - globalisation and
full spectrum offering.
Established in September 2004, the company has completed over 1500 clinical
studies, 300 ANDA studies and received 50 product approvals from regulatory
agencies. The company facilities have been accredited by DCGI (Drugs Controller
General, India), NABL (National Accreditation Board for Testing and Calibration
Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA
and France AFSSAPS and conforms to ICH and CDSCO-GCP & GLP Guidelines. For
further details, please visit – www.axisclinicals.com
For further
details, contact:
Shankar
Chelluri, S Paradigm Consultants, PH: +91.99490.93501
